Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125086102 | 12508610 | 2 | F | 20160508 | 20160707 | 20160629 | 20160721 | EXP | GB-CELGENEUS-GBR-2016052651 | CELGENE | 63.00 | YR | M | Y | 0.00000 | 20160721 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125086102 | 12508610 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | 21880 | 25 | MG | CAPSULES | |||||||
| 125086102 | 12508610 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | 21880 | 25 | MG | CAPSULES | |||||||
| 125086102 | 12508610 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Oral | U | 0 | 500 | MG | TABLETS | |||||||
| 125086102 | 12508610 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Oral | U | 0 | 500 | MG | TABLETS | |||||||
| 125086102 | 12508610 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 40 | MG | TABLETS | |||||||
| 125086102 | 12508610 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 40 | MG | TABLETS | |||||||
| 125086102 | 12508610 | 7 | SS | carfilzomib | CARFILZOMIB | 1 | Intravenous drip | U | 0 | 36 | MG/M**2 | INJECTION | |||||||
| 125086102 | 12508610 | 8 | SS | carfilzomib | CARFILZOMIB | 1 | Intravenous drip | U | 0 | 36 | MG/M**2 | INJECTION | |||||||
| 125086102 | 12508610 | 9 | SS | ZOLEDRONIC ACID. | ZOLEDRONIC ACID | 1 | Unknown | U | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125086102 | 12508610 | 1 | Plasma cell myeloma |
| 125086102 | 12508610 | 3 | Plasma cell myeloma |
| 125086102 | 12508610 | 5 | Plasma cell myeloma |
| 125086102 | 12508610 | 7 | Plasma cell myeloma |
| 125086102 | 12508610 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125086102 | 12508610 | DE |
| 125086102 | 12508610 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125086102 | 12508610 | Deep vein thrombosis | |
| 125086102 | 12508610 | Malaise | |
| 125086102 | 12508610 | Pulmonary embolism | |
| 125086102 | 12508610 | Pyrexia | |
| 125086102 | 12508610 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125086102 | 12508610 | 1 | 20160316 | 20160420 | 0 | |
| 125086102 | 12508610 | 2 | 20160316 | 20160609 | 0 | |
| 125086102 | 12508610 | 3 | 20160316 | 20160421 | 0 | |
| 125086102 | 12508610 | 4 | 20160316 | 20160602 | 0 | |
| 125086102 | 12508610 | 5 | 20160316 | 20160429 | 0 | |
| 125086102 | 12508610 | 6 | 20160316 | 20160610 | 0 | |
| 125086102 | 12508610 | 7 | 20160316 | 20160429 | 0 | |
| 125086102 | 12508610 | 8 | 20160316 | 20160610 | 0 |